-
1.
公开(公告)号:EP1294713A2
公开(公告)日:2003-03-26
申请号:EP01948740.4
申请日:2001-06-26
发明人: ZHANG, Wentao , LIEHR, Sebastian, Johannes, R. , VELLIGAN, Mark, Douglas , DYATKINA, Natalia B. , BOTYANSZKI, Janos , SHI, Dong-Fang , ROBERTS, Christopher, Don , KHORLIN, Alexander , NELSON, Peter, Harold , MUCHOWSKI, Joseph, Martin
IPC分类号: C07D403/14 , A61K31/395 , A61P31/00 , A61P35/00 , C07D209/42 , C07D207/34 , C07D409/14 , C07D401/14
CPC分类号: C07D401/14 , C07D207/34 , C07D209/42 , C07D403/14 , C07D409/14
摘要: The present invention provides novel compounds possessing one or more of the following activities: antibacterial, antifungal and antitumor activity. The compounds are of Formula (I): wherein: Z?1 and Z2¿ are independently-NR3-(wherein R3 is hydrogen or alkyl) or -O-; R?1 and R2¿ are independently substituted alkyl, substituted aryl, heteroaryl, or substituted heteroaryl provided that at least one of R?1 and R2¿ is a group that can form a pharmaceutically acceptable acid addition salt; R3 is hydrogen, alkyl or R?3 and R1 or R2¿ together with the atoms to which they are attached form a heterocyclic ring; X2 is aryl, substituted aryl, heteroaryl, substituded heteroaryl, alkenyl, alkynyl, cycloalkyl or heterocyclic; X?1 and X3¿ are independently aryl, substituted aryl, heteroaryl, substituted heteroaryl, or-CHR4, wherein R4 is natural or unnatural amino acid side chain; or a pharmaceutically acceptable acid addition salt thereof.Pharmaceutical compositions containing these compounds, methods of making and methods for using these compounds are also provided.